Maternal effector T cells within decidua: The adaptive immune response to pregnancy?

Placenta

Volumn 60, Issue , 2017, Pages 140-144

  Lissauer, D ^a   Kilby, M D ^a   Moss, P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Decidua; Effector T cell; Interferon

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; CXCL10 PROTEIN, HUMAN; CXCR3 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ARTICLE; CELL FUNCTION; CELL SPECIFICITY; DECIDUA; EFFECTOR CELL; FEMALE; FETUS; FETUS TISSUE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MICROCHIMERISM; NONHUMAN; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; CHIMERA; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PLACENTA DISORDER;

ADAPTIVE IMMUNITY; ANIMALS; CHEMOKINE CXCL10; CHIMERISM; DECIDUA; FEMALE; HUMANS; PLACENTA DISEASES; PREGNANCY; RECEPTORS, CXCR3; T-LYMPHOCYTES;

EID: 85031807714     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2017.09.003     Document Type: Article

References (52)

1. Moffett, A., Loke, C., Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 6 (2006), 584–594.
2. Stallmach, T., Hebisch, G., Orban, P., Lu, X., Aberrant positioning of trophoblast and lymphocytes in the feto-maternal interface with pre-eclampsia. Virchows Arch. 434:3 (1999), 207–211.
3. Sykes, L., MacIntyre, D.A., Yap, X.J., Teoh, T.G., Bennett, P.R., Sykes, L., MacIntyre, D.A., Yap, X.J., Teoh, T.G., Bennett, P.R., The Th1:Th2 dichotomy of pregnancy and preterm labour. Mediat. Inflamm., 2012, 1–12.
4. Williams, P.J., Searle, R.F., Robson, S.C., Innes, B.A., Bulmer, J.N., Decidual leucocyte populations in early to late gestation normal human pregnancy. J. Reprod. Immunol. 82 (2009), 24–31.
5. Powell, R., Lissauer, D., Tamblyn, J., Beggs, A., Cox, P., Moss, P., Kilby, M.D., Decidual T cells exhibit a highly differentiated phenotype and demonstrate potential fetal-specificity and a strong transcriptional response to interferon. J. Immunol., 2017 Oct 6, 10.4049/jimmunol.1700114 pii: ji1700114.
6. Tilburgs, T., Scherjon, S.A., van der Mast, B.J., Haasnoot, G.W., Versteeg, M., Voort-Maarschalk, V.D., Roelen, D.L., van Rood, J.J., Claas, F.H.J., Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J. Reprod. Immunol. 82 (2009), 148–157.
7. Nancy, P., Erlebacher, A., Epigenetic repression of chemokine expression at the maternal-fetal interface as a mechanism of feto-maternal tolerance. Médecine Sci. M/S 28 (2012), 1037–1039.
8. Chaturvedi, V., Ertelt, J.M., Jiang, T.T., Kinder, J.M., Xin, L., Owens, K.J., Jones, H.N., Way, S.S., CXCR3 blockade protects against Listeria monocytogenes infection-induced fetal wastage. J. Clin. Invest. 125:4 (2015), 1713–1725.
9. Masson, E., Vidal, C., Deschamps, M., Bongain, S., Thevenin, C., Dupont, I., Rietmulher, D., Pouthier, F., Mongaillard, G., Chabod, J., Ferrand, C., Tiberghien, P., Rebibou, J.M., Incidence and risk factors of anti-HLA immunization after pregnancy. Hum. Immunol. Aug;74:8 (2013), 946–951.
10. Meuleman, T., van Beelen, E., Kaaja, R.J., van Lith, J.M., Claas, F.H., Bloemenkamp, K.W., HLA-C antibodies in women with recurrent miscarriage suggests that antibody mediated rejection is one of the mechanisms leading to recurrent miscarriage. J. Reprod. Immunol. 116 (2016), 28–34.
11. van Kampen, C.A., Versteeg-van der Voort Maarschalk, M.F., Langerak-Langerak, J., van Beelen, E., Roelen, D.L., Claas, F.H., Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum. Immunol. Mar;62:3 (2001), 201–207.
12. Lissauer, D., Piper, K., Goodyear, O., Kilby, M.D., Moss, P.A.H., Fetal-specific CD8+ cytotoxic T cell responses develop during normal human pregnancy and exhibit broad functional capacity. J. Immunol. 189 (2012), 1072–1080.
13. Piper, K.P., McLarnon, A., Arrazi, J., Horlock, C., Ainsworth, J., Kilby, M.D., Martin, W.L., Moss, P., Functional HY-specific CD8+ T cells are found in a high proportion of women following pregnancy with a male fetus. Biol. Reprod. 76 (2007), 96–101.
14. Verdijk, R.M., Kloosterman, A., Pool, J., van de Keur, M., Naipal, A.M.I.H., van Halteren, A.G.S., Brand, A., Mutis, T., Goulmy, E., Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 103 (2004), 1961–1964.
15. Verdijk, R.M., Kloosterman, A., Pool, J., van de Keur, M., Naipal, A.M.I.H., van Halteren, A.G.S., Brand, A., Mutis, T., Goulmy, E., Pregnancy induces minor histocompatibility antigen–specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood, 2004, 103.
16. van Halteren, A.G.S., Jankowska-Gan, E., Joosten, A., Blokland, E., Pool, J., Brand, A., Burlingham, W.J., Goulmy, E., Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood, 2009, 114.
17. Tilburgs, T., Schonkeren, D., Eikmans, M., Nagtzaam, N.M., Datema, G., Swings, G.M., Prins, F., van Lith, J.M., van der Mast, B.J., Roelen, D.L., Scherjon, S.A., Claas, F.H., Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties. J. Immunol. 185 (2010), 4470–4477.
18. Lissauer, D., Eldershaw, S.A., Inman, C.F., Coomarasamy, A., Moss, P.A.H., Kilby, M.D., Progesterone promotes maternal-fetal tolerance by reducing human maternal T-cell polyfunctionality and inducing a specific cytokine profile. Eur. J. Immunol. 45 (2015), 2858–2872.
19. Raghupathy, R., Al Mutawa, E., Makhseed, M., Azizieh, F., Szekeres-Bartho, J., Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. BJOG 112 (2005), 1096–1101.
20. Chard, T., Craig, P.H., Menabawey, M., Lee, C., Alpha interferon in human pregnancy. Br. J. Obstet. Gynaecol. 93 (1986), 1145–1149.
21. Khan, N.U., Gibson, A., Foulis, A.K., The distribution of immunoreactive interferon-alpha in formalin-fixed paraffin-embedded normal human foetal and infant tissues. Immunology 71 (1990), 230–235.
22. Bannert, N., Kurth, R., Retroelements and the human genome: new perspectives on an old relation. Proc. Natl. Acad. Sci. U. S. A., 2004, 14572–14579.
23. Tristem, M., Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J. Virol. 74 (2000), 3715–3730.
24. Blond, J.L., Besème, F., Duret, L., Bouton, O., Bedin, F., Perron, H., Mandrand, B., Mallet, F., Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J. Virol. 73 (1999), 1175–1185.
25. McCoy, J.M., Mi, S., Lee, X., Li, X., Veldman, G.M., Finnerty, H., Racie, L., LaVallie, E., Tang, X.-Y., Edouard, P., Howes, S., Keith, J.C., Syncytin is a captive retroviral envelope protein involved in human placentalmorphogenesis. Nature 403 (2000), 785–789.
26. Kämmerer, U., Germeyer, A., Stengel, S., Kapp, M., Denner, J., Human endogenous retrovirus K (HERV-K) is expressed in villous and extravillous cytotrophoblast cells of the human placenta. J. Reprod. Immunol. 91 (2011), 1–8.
27. Holder, B.S., Tower, C.L., Forbes, K., Mulla, M.J., Aplin, J.D., Abrahams, V.M., Immune cell activation by trophoblast-derived microvesicles is mediated by syncytin 1. Immunology 136 (2012), 184–191.
28. Crespo, Â.C., van der Zwan, A., Ramalho-Santos, J., Strominger, J.L., Tilburgs, T., Cytotoxic potential of decidual NK cells and CD8+ T cells awakened by infections. J. Reprod. Immunol. Feb;119 (2017), 85–90.
29. van Egmond, A., van der Keur, C., Swings, G.M., Scherjon, S.A., Claas, F.H., The possible role of virus-specific CD8(+) memory T cells in decidual tissue. J. Reprod. Immunol. Feb;113 (2016), 1–8.
30. Crespo, Â.C., Strominger, J.L., Tilburgs, T., Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection. Proc. Natl. Acad. Sci. U. S. A. 113:52 (2017), 15072–15077.
31. Rowe, J.H., Ertelt, J.M., Xin, L., Way, S.S., Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490 (2012), 102–106.
32. Aluvihare, V.R., Kallikourdis, M., Betz, A.G., Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5 (2004), 266–271.
33. Tilburgs, T., Roelen, D.L., van der Mast, B.J., de Groot-Swings, G.M., Kleijburg, C., Scherjon, S.A., Claas, F.H., Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J. Immunol. 180 (2008), 5737–5745.
34. Chen, T., Darrasse-Jèze, G., Bergot, A.S., Courau, T., Churlaud, G., Valdivia, K., Strominger, J.L., Ruocco, M.G., Chaouat, G., Klatzmann, D., Self-specific memory regulatory T cells protect embryos at implantation in mice. J. Immunol. 191:5 (2013), 2273–2281.
35. Samstein, R.M., Arvey, A., Josefowicz, S.Z., Peng, X., Reynolds, A., Sandstrom, R., Neph, S., Sabo, P., Kim, J.M., Liao, W., Li, M.O., Leslie, C., Stamatoyannopoulos, J.A., Rudensky, A.Y., Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151 (2012), 153–166.
36. Liang, S.C., Latchman, Y.E., Buhlmann, J.E., Tomczak, M.F., Horwitz, B.H., Freeman, G.J., Sharpe, A.H., Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33 (2003), 2706–2716.
37. Tanaka, K., Albin, M.J., Yuan, X., Yamaura, K., Habicht, A., Murayama, T., Grimm, M., Waaga, A.M., Ueno, T., Padera, R.F., Yagita, H., Azuma, M., Shin, T., Blazar, B.R., Rothstein, D.M., Sayegh, M.H., Najafian, N., PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. J. Immunol. 179 (2007), 5204–5210.
38. Topalian, S.L., Hodi, F.S., Brahmer, J.R., Gettinger, S.N., Smith, D.C., McDermott, D.F., Powderly, J.D., Carvajal, R.D., Sosman, J.A., Atkins, M.B., Leming, P.D., Spigel, D.R., Antonia, S.J., Horn, L., Drake, C.G., Pardoll, D.M., Chen, L., Sharfman, W.H., Anders, R.A., Taube, J.M., McMiller, T.L., Xu, H., Korman, A.J., Jure-Kunkel, M., Agrawal, S., McDonald, D., Kollia, G.D., Gupta, A., Wigginton, J.M., Sznol, M., Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366 (2012), 2443–2454.
39. Guleria, I., Khosroshahi, A., Ansari, M.J., Habicht, A., Azuma, M., Yagita, H., Noelle, R.J., Coyle, A., Mellor, A.L., Khoury, S.J., Sayegh, M.H., A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med., 2005, 202.
40. Wang, S., Zhu, X., Xu, Y., Zhang, D., Li, Y., Tao, Y., Piao, H., Li, D., Du, M., Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface. Hum. Reprod. 31 (2016), 700–711.
41. Chabtini, L., Mfarrej, B., Mounayar, M., Zhu, B., Batal, I., Dakle, P.J., Smith, B.D., Boenisch, O., Najafian, N., Akiba, H., Yagita, H., Guleria, I., TIM-3 regulates innate immune cells to induce fetomaternal tolerance. J. Immunol. 190 (2013), 88–96.
42. Veras, E., Kurman, R.J., Wang, T.-L., Shih, I.-M., PD-L1 expression in human placentas and gestational trophoblastic diseases. Int. J. Gynecol. Pathol. Mar;36:2 (2017), 146–153.
43. Wang, S.-C., Li, Y.-H., Piao, H.-L., Hong, X.-W., Zhang, D., Xu, Y.-Y., Tao, Y., Wang, Y., Yuan, M.-M., Li, D.-J., Du, M.-R., PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy. Cell Death Dis., 6, 2015, e1738.
44. Old, L.J., Cancer is a somatic cell pregnancy. Cancer Immun., Nov 6(7), 2007, 19.
45. Bianchi, D.W., Progress in the genetic analysis of fetal cells circulating in maternal blood. Curr. Opin. Obstet. Gynecol. 9:2 (1997), 121–125.
46. Gammill, H.S., Guthrie, K.A., Aydelotte, T.M., Adams Waldorf, K.M., Nelson, J.L., Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host?. Blood 116:15 (2010), 2706–2712.
47. Leavey, K., Benton, S.J., Grynspan, D., Kingdom, J.C., Bainbridge, S.A., Cox, B.J., Unsupervised placental gene expression profiling identifies clinically relevant subclasses of human preeclampsia. Hypertens 68 (2016), 137–147.
48. Kapur, P., Rakheja, D., Gomez, A.M., Sheffield, J., Sanchez, P., Rogers, B.B., Characterization of inflammation in syphilitic villitis and in villitis of unknown etiology. Pediatr. Dev. Pathol. 7 (2004), 453–458.
49. Redline, R.W., Patterson, P., Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am. J. Pathol. 143 (1993), 473–479.
50. Redline, R.W., Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum. Pathol. 38 (2007), 1439–1446.
51. Tamblyn, J.A., Lissauer, D.M., Powell, R., Cox, P., Kilby, M.D., The immunological basis of villitis of unknown etiology – Review. Placenta 34 (2013), 846–855.
52. Faas, M.M., de Vos, P., Uterine NK cells and macrophages in pregnancy. Placenta Aug;56 (2017), 44–52.